Skip to main content

Cookies on UKHSA data dashboard

We use some essential cookies to make this service work.

We'd like to set additional cookies so we can remember your settings, understand how people use the service and make improvements.

View cookies
UKHSA data dashboard

BetaThis is a new service - your feedback will help us to improve it.

Information
Correction to COVID-19 case rates data

Between 10 April and 27 April, published rolling-average case rates for COVID-19 were incorrect due to an error in population estimates used to calculate these metrics. As of 4pm on 28 April, these have been corrected. More information.

BackEntry title:

Hepatitis C yearly deaths per 100,000 population

Last updated on Thursday, 10 April 2025 at 03:30pm

Summary

Topic
Hepatitis-C
Category
headline
API name
hepatitis-c_headline_HCVmortalityLatest

Rationale

Hepatitis C virus-related mortality is an important measure as it monitors whether services are promptly diagnosing and treating people living with hepatitis C. Prompt diagnosis and treatment reduces the number of deaths related to hepatitis C virus by ensuring early clearance of the infection before it can cause damage to the liver.

Definition

This metric shows the annual number of death registrations from hepatitis C virus-related End-Stage Liver Disease (ESLD) and/or hepatocellular carcinoma (HCC) in England, per 100,000 population.

Methodology

Deaths are based on the year they were registered.

The number of deaths per year where hepatitis C is mentioned on the death certificate along with codes and text entries for ESLD and/or HCC are used to calculate the rate per 100,000 population using Office for National Statistics (ONS) mid-year population estimates for England.

Caveats

Death registrations for England are those where hepatitis C is mentioned on the death certificate and excludes deaths registered in England where the deceased’s usual residence is outside of England.

Hepatitis C related End-Stage Liver Disease is defined by codes or text entries for ascites, bleeding oesophageal varices, hepato-renal syndrome, hepatic encephalopathy, or hepatic failure.

Back to top